06-30 GNI Group Ltd. completed the acquisition of AYUMI Pharmaceutical Corporation from Blackstone Inc. (NYSE:BX), Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. CI
06-07 GNI to Acquire Ayumi Pharmaceutical in 44.8 Billion Yen Deal; Blackstone-Backed Fund Becomes Top Shareholder MT
06-04 GNI Group Ltd. agreed to acquire AYUMI Pharmaceutical Corporation from Blackstone Inc. (NYSE:BX), Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. for ¥44.8 billion. CI
05-10 Hisamitsu Pharmaceutical Co., Inc.(TSE:4530) dropped from FTSE All-World Index CI
04-24 The Bank of Saga Ltd. Revises Consolidated and Non-Consolidated Earnings Guidance for the Year Ended March 31, 2026 CI
04-22 Hisamitsu Pharmaceutical Co., Inc.(TSE:4530) dropped from S&P Global BMI Index CI
04-22 Hisamitsu Pharmaceutical Co., Inc.(TSE:4530) dropped from S&P Japan 500 CI
04-17 Hisamitsu Pharma to Delist After Share Consolidation Approval MT
04-13 U.S International Trade Commission Institutes Investigation Against Veridian Healthcare LLC, Perrigo Company PLC, Perrigo Company, Perrigo Direct Inc, Opella Healthcare Group SAS, Opella North America, Chattem Inc, Hisamitsu Pharmaceutical Co Inc, Hisamitsu U.S Inc, Hisamitsu America Inc, Reckitt Benckiser Group PL, Reckitt Benckiser LLC, RB Health LLC For Alleged Patent Infringement Of Over-The-Counter Topical Lidocaine Patches CI
04-13 Hisamitsu Pharmaceutical's Full-Year Profit Drops 12% MT
04-13 Hisamitsu Pharmaceutical Co., Inc. Announces No Dividend for the Fiscal Year Ended February 28, 2026 CI
03-13 Hisamitsu Pharmaceutical To Seek Share Consolidation Ahead Of Planned Delisting MT
03-13 Hisamitsu Pharmaceutical Co Inc to retire treasury shares worth 6.34% of outstanding stock on May 12 RE
Manager TitleAgeSince
President 54 2015-04-30
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 63 -
Director TitleAgeSince
Director/Board Member 54 2007-04-30
Director/Board Member 63 2013-04-30
Director/Board Member 62 2014-04-30
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.69B
+0.85%-0.80%+54.84%+163.70% 1,051B
+1.23%-1.53%+55.26%+59.07% 609B
+0.04%+2.58%+32.96%+88.75% 450B
+0.78%-0.71%+30.04%+24.61% 330B
+1.41%+0.58%+33.92%+47.20% 284B
-0.27%-1.87%+22.13%+23.47% 263B
-1.76%+2.37%-22.19%-38.45% 223B
-1.42%+0.80%+22.81%+60.77% 198B
-1.48%+3.43%+23.42%+73.31% 167B
Average -0.11%+0.54%+28.13%+55.82% 397.23B
Weighted average by Cap. +0.22%+0.02%+37.75%+81.49%
Logo Hisamitsu Pharmaceutical Co., Inc.
Hisamitsu Pharmaceutical Co Inc is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the manufacture, sale and supply of pharmaceuticals and related products, and the operation of over-the-counter drug (OTC) business. It is also engaged in the manufacture and sale of drugs in the United States, Brazil, Vietnam, and Indonesia, the development work in Europe, the drug marketing and sales in China and Hong Kong. It is also engaged in the urban cable television broadcasting business, Internet connection service business, non-life insurance agency business, advertising agency business and the purchase, manufacture and sale of packing materials.
Employees
2,799
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. 4530 Stock